Evidence map›Paper›PMID 38135766›Full record

ArticleScientific reports2023

Using machine learning model explanations to identify proteins related to severity of meibomian gland dysfunction.

Andrea M Storås, Fredrik Fineide, Morten Magnø, Bernd Thiede, Xiangjun Chen, Inga Strümke, Pål Halvorsen, Hilde Galtung, Janicke L Jensen, Tor P Utheim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Andrea M StoråsDepartment of Holistic Systems, Simula Metropolitan Center for Digital Engineering, Oslo, Norway. andrea@simula.no.
Fredrik FineideDepartment of Computer Science, OsloMet - Oslo Metropolitan University, Oslo, Norway.
Morten MagnøDepartment of Ophthalmology, Sørlandet Hospital Arendal, Arendal, Norway.
Bernd ThiedeDepartment of Biosciences, University of Oslo, Oslo, Norway.
Xiangjun ChenDepartment of Ophthalmology, Sørlandet Hospital Arendal, Arendal, Norway.
Inga StrümkeDepartment of Computer Science, Norwegian University of Science and Technology, Trondheim, Norway.
Pål HalvorsenDepartment of Holistic Systems, Simula Metropolitan Center for Digital Engineering, Oslo, Norway.
Hilde GaltungInstitute of Oral Biology, University of Oslo, Oslo, Norway.
Janicke L JensenDepartment of Oral Surgery and Oral Medicine, University of Oslo, Oslo, Norway.
Tor P UtheimDepartment of Computer Science, OsloMet - Oslo Metropolitan University, Oslo, Norway.
Michael A RieglerDepartment of Holistic Systems, Simula Metropolitan Center for Digital Engineering, Oslo, Norway.
OsloMet – Oslo Metropolitan University · NOUniversity of Oslo · NONorwegian University of Science and Technology · NOOslo University Hospital · NOSimula Metropolitan Center for Digital Engineering · NOSørlandet Hospital Arendal · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meibomian gland dysfunction is the most common cause of dry eye disease and leads to significantly reduced quality of life and social burdens. Because meibomian gland dysfunction results in impaired function of the tear film lipid layer, studying the expression of tear proteins might increase the understanding of the etiology of the condition. Machine learning is able to detect patterns in complex data. This study applied machine learning to classify levels of meibomian gland dysfunction from tear proteins. The aim was to investigate proteomic changes between groups with different severity levels of meibomian gland dysfunction, as opposed to only separating patients with and without this condition. An established feature importance method was used to identify the most important proteins for the resulting models. Moreover, a new method that can take the uncertainty of the models into account when creating explanations was proposed. By examining the identified proteins, potential biomarkers for meibomian gland dysfunction were discovered. The overall findings are largely confirmatory, indicating that the presented machine learning approaches are promising for detecting clinically relevant proteins. While this study provides valuable insights into proteomic changes associated with varying severity levels of meibomian gland dysfunction, it should be noted that it was conducted without a healthy control group. Future research could benefit from including such a comparison to further validate and extend the findings presented here.

Indexed as

Dry Eye SyndromesMeibomian Gland DysfunctionHumansMeibomian GlandsProteomicsQuality of LifeTears

Identifiers

PMID38135766
PMCPMC10746717
OpenAlexW4390109217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.